Rare diseases
Investigational molecules
Locations
293 conditions with trials, the busiest first
1 664 trials across Europe, recruiting first
A Phase 2 Study of LAD603 in Adults with Systemic Lupus Erythematosus and Active Skin Rash
BulgariaSafety and efficacy of GS-3242 drug combination compared with standard drug combination in treatment‑naive adults with HIV‑1
GermanyStudy of Fostemsavir in Adults with HIV Transitioning from Prior ViiV Clinical Trials for Continued Treatment Access
RomaniaAdd‑on Unsaturated Fatty Acids with TNF‑Alpha Inhibitor Drug Combination in Patients with Psoriatic Arthritis
ItalyLong‑Term Safety and Tolerability of Oral Iptacopan in Pediatric Patients with Paroxysmal Nocturnal Hemoglobinuria or IgA Nephropathy
ItalyStudy of ARGX-121 to Reduce Proteinuria in Adults with Primary IgA Nephropathy (IgAN)
BelgiumOptimizing biologic tapering in patients with rheumatoid arthritis using tocilizumab, drug combination, and olfactory placebo conditioning
The NetherlandsSafety and Efficacy of Saroglitazar Magnesium in Patients with Primary Biliary Cholangitis: A Long‑Term Randomized Placebo‑Controlled Study
BulgariaEfficacy of upadacitinib plus short prednisolone tapering in adults with Giant Cell Arteritis
GermanyPrecision Monitoring of Tacrolimus and Mycophenolate Mofetil in Adult Liver Transplant Recipients: Randomized Controlled Trial
FranceEvaluation of Upadacitinib for Reducing Ileal Strictures in Patients with Crohn’s Disease
BelgiumEfficacy and safety of house dust mite allergoid (Dermatophagoides farinae, D. pteronyssinus, aluminium hydroxide) in people with moderate to severe house dust mite allergy
SpainThe therapies tested most often in Immune system disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
